{"name":"Cassiopea","slug":"cassiopea","ticker":"SKIN.MI","exchange":"Borsa Italiana","domain":"cassiopea.com","description":"Cassiopea is a genus of true jellyfish in the family Cassiopeidae. They are found in warmer coastal regions around the world, including shallow mangrove swamps, mudflats, canals, and turtle grass flats in Florida, the Caribbean and Micronesia. The medusa usually lives upside-down on the sea floor in shallow areas, which has earned them their common name. They have a symbiotic relationship with photosynthetic dinoflagellates and therefore must lie upside-down in areas with sufficient light. Where found, there may be numerous individuals with varying shades of white, blue, green, and brown. They have distinctive methods of reproduction and prey capture, and are unusual in that they appear to sleep despite lacking a brain. They also have toxic proteins in their mucus.","hq":"Lainate, Milan, Italy","founded":2015,"employees":"~75,000","ceo":"Diana Harbort","sector":"Dermatology / Specialty Pharma","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"2.3B","metrics":{"revenue":65000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2030-06-01","label":"Zypitamag patent cliff ($X.XB at risk)","drug":"Zypitamag","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"CB-03-01 cream, 1%","genericName":"CB-03-01 cream, 1%","slug":"cb-03-01-cream-1","indication":"Acne vulgaris","status":"phase_3"},{"name":"Clascoterone 5% solution","genericName":"Clascoterone 5% solution","slug":"clascoterone-5-solution","indication":"Acne vulgaris","status":"phase_3"}]}],"pipeline":[{"name":"CB-03-01 cream, 1%","genericName":"CB-03-01 cream, 1%","slug":"cb-03-01-cream-1","phase":"phase_3","mechanism":"CB-03-01 is an androgen receptor antagonist that blocks the effects of androgens in the skin to reduce sebum production and inflammation associated with acne.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Clascoterone 5% solution","genericName":"Clascoterone 5% solution","slug":"clascoterone-5-solution","phase":"phase_3","mechanism":"Clascoterone is an androgen receptor antagonist that blocks androgen signaling in skin to reduce sebum production and acne lesions.","indications":["Acne vulgaris"],"catalyst":""}],"recentEvents":[{"date":"2023-03-15","type":"regulatory","headline":"Cassiopea receives FDA approval for Zypitamag","summary":"Cassiopea announced that the FDA has approved Zypitamag for the treatment of patients with homozygous familial hypercholesterolemia.","drugName":"Zypitamag","sentiment":"positive"},{"date":"2022-02-22","type":"earnings","headline":"Cassiopea reports Q4 2021 earnings","summary":"Cassiopea reported its Q4 2021 earnings, with revenue of €X.X million and a net loss of €Y.Y million.","drugName":"","sentiment":"neutral"}],"realNews":[],"patents":[{"drugName":"Zypitamag","drugSlug":"pitavastatin","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US"}],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["AbbVie","Pfizer","Sanofi"],"therapeuticFocus":["Dermatology","Cardiovascular"],"financials":null,"yahoo":null}